Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution

Summary

This is a randomised, open-label, 3-period, crossover single dose study to assess the relative bioavailability of two formulations of HTL0016878: an oral solution of HCl salt form (the reference product) and an oral capsule containing citrate salt (the test product); and of the effect of food on the pharmacokinetics of the capsule formulation.

Timeline

Start

2021-07-29

Primary completion

2021-10-29

Completion

2021-10-29

Drugs

Indications

No indication recorded.